ArticlePediatrics international : official journal of the Japan Pediatric Society

Optimizing risk factors to guide COST-effective use of palivizumab in KOREAN infants.

Ji-Man Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.